c‐KIT‐ERK1/2 signaling activated ELK1 and upregulated carcinoembryonic antigen expression to promote colorectal cancer progressionJian Ma, Deshan Zhou, Xiaohui Liu et al.|Cancer Science|2020Cited by 27
P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST-IN-HUMAN STUDYPinkal Desai, Tapan M. Kadia, James S. Blachly et al.|HemaSphere|2023Cited by 6